| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | 1,369 | 1,556 | 1,860 | 863 |
| Net loss | -21,528 | -21,254 | -20,311 | -17,472 |
| Unrealized gain (loss) on investments, net | - | 2 | 129 | 217 |
| Unrealized gain on investments, net | 85 | - | - | - |
| Comprehensive loss | -21,443 | -21,252 | -20,182 | -17,255 |
| Earnings per share, basic | -0.88 | -0.87 | -0.83 | -0.92 |
| Earnings per share, diluted | -0.88 | -0.87 | -0.83 | -0.92 |
| Weighted average number of shares outstanding, basic | 24,481,722 | 24,378,823 | 24,341,978 | 18,896,829 |
| Weighted average number of shares outstanding, diluted | 24,481,722 | 24,378,823 | 24,341,978 | 18,896,829 |
Artiva Biotherapeutics, Inc. (ARTV)
Artiva Biotherapeutics, Inc. (ARTV)